Posts Tagged ‘FDA’
FDA Alert: MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug
This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. May 11, 2020 Company Contact Information Consumers: Lin Leung, MasterPharm, LLC Phone: (866) 630-5600 Email: recall@masterpharm.com…
[...]Former FDA Associate Commissioner Warns of the “Massive Safety Risks of Importation”
Source: Twitter This editorial by Peter J. Pitts was published in The Times Weekly on March 3, 2020. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner. Keep Canadian drugs out of U.S. medicine cabinets The Trump administration recently proposed two rules that would allow…
[...]FDA Worked With Indian Government To Seize 500 Counterfeit Drug Shipments in January
The U.S. Food and Drug Administration (FDA) has just announced a successful joint operation with the Government of India targeting counterfeit prescription drugs, counterfeit over-the-counter medications, fake medical devices, and misbranded dietary supplements containing harmful ingredients.
[...]Website Operators Warned by FDA/DEA Offered Antibiotics, Cancer & HIV Treatments in Addition to Misbranded Opioids
On September 30th, the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) issued a joint warning to four online networks that were operating a total of ten fake online pharmacy websites. While all four networks were offering misbranded/counterfeit opioid medications such as tramadol and Soma for sale, three of the online networks had marketplaces offering misbranded medications to treat a kaleidoscope of ailments, such as allergies, cancer, smoking, asthma, and infection.
[...]Canadians Concerned About US Prescription Drug Importation Proposals
John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.
[...]Prime Minister Trudeau Promises to Protect the Canadian Drug Supply In The Face Of The U.S. Drug Importation Statement
Canadian Prime Minister Justin Trudeau was interviewed today in Iqaluit, and according to CBC Canada, he reassured Canadians that Health Canada is already safeguarding the Canadian prescription drug supply regardless of international pressure.
[...]New Analysis by HDA Finds Importation Proposals Are Too Expensive and Pose Health Risks to Patients
A report just released the HDA Research Foundation demonstrates that federal importation proposals to allow drug importation are devoid of practical implementation guidance and funding, so will fail to guarantee federal safety and quality standards for prescription medication.
[...]U.S. FDA Issued Warning Letters About Misbranded Mifepristone And Misoprostol
In March 2019, the U.S. Food and Drug Administration issued warning letters to a website and an online pharmacy network for selling misbranded mifepristone and misoprostol
[...]Millions Of Pills Sold As Herbal Supplements Contained An Active Pharmaceutical Ingredient
Three individuals and four companies have pending plea agreements in federal court on charges related to the illegal importation and sale of $11 million worth of herbal remedies that contained an undisclosed active pharmaceutical ingredient. Over several years, two of the individuals involved manufactured millions of pills…
[...]Keeping The Drug Supply Chain Safe Keeps Patients Safe
In a statement from the U.S. Food and Drug Administration, Commissioner Scott Gottlieb, M.D. discussed the agency’s continuing efforts to combat the spread of illicit opioids and to ensure the security of America’s drug supply chain. Included in their recent efforts, Commissioner Gottlieb noted that the agency has stepped up enforcement and interdiction work at International Mail Facilities and shut down websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid medications to U.S. citizens…
[...]